A research platform leveraging extracellular vesicles (EVs) isolated from extremophilic microbes to enhance soil fertility, boost plant tolerance to pests and pathogens, and raise agricultural output. EVs enable study of unculturable extreme-environment microbes without requiring lab cultivation.
This research explores the agricultural potential of microbes that thrive in extreme environments by studying the extracellular vesicles (EVs) they naturally release. These EVs carry bioactive compounds that can influence plant health, soil fertility, and pathogen resistance. By isolating EVs directly from environmental samples, this approach bypasses the challenge of culturing extremophilic microbes in the lab, making it possible to harness their biological functions for agricultural benefit.
The platform addresses key agricultural needs including improved soil fertility, enhanced plant tolerance to pests and pathogens, and increased crop output, all through environmentally acceptable biological mechanisms. EVs from extreme environments represent an untapped resource of bioactive molecules with potential applications in crop protection and production.
Core approach:
Key capabilities demonstrated:
Research workflow:
This research is at an early-to-mid stage of development. The team has already demonstrated the ability to extract EVs from multiple biological sources and has conducted uptake studies showing that EVs can produce measurable phenotypic effects in recipient microbes. Current work involves an active field collection expedition through the South African National Antarctic Programme to gather samples from extreme environments.
The next validation phases include isolating and characterizing EVs from collected extreme-environment samples (projected June–August 2022), followed by systematic bioactivity testing in plant hosts and microbial pathogens (projected September–December 2022). The platform is positioned for collaborative development with partners interested in sustainable agricultural solutions and novel bioactive compound discovery.
UP is a comprehensive, multi‑campus public research university in Pretoria with a broad disciplinary base and significant postgraduate activity. Industry engages through co‑located, large‑scale labs at the Engineering 4.0 campus—home to national reference and training facilities developed with SANRAL and partners—and through clinical pathways via Steve Biko Academic Hospital. For streamlined collaboration, Enterprises University of Pretoria serves as a single contracting gateway for contract research and consulting, while a dedicated Technology Transfer Office manages IP and licensing. Research is supported by South Africa’s National Research Foundation and the South African Medical Research Council, alongside international sponsors. Startup creation is enabled by the on‑campus TuksNovation incubator.